| http://www.w3.org/ns/prov#value | - lth Research Institute in Seattle, who is also a member of PROP, said the move is a step in the right direction, but said that overall the agency's actions on the opioid epidemic leave something to be desired.It is not clear to me why the FDA's actions apply only to long-acting opioids when similar cautions apply to short-acting opioids, like Vicodin, Von Korff said in an email.Von Korff added t
|
